Literature DB >> 7213574

Liposome-encapsulated desferrioxamine in experimental iron overload.

E H Lau, E A Cerny, Y E Rahman.   

Abstract

We have encapsulated desferrioxamine (DF) in multilamellar liposomes (ML) and unilamellar liposomes (UL). Liposomes were prepared either with or without a glycolipid, i..e. galactocerebroside (GC). The average diameter of ML was 0.5 microgram, and that of UL was 0.08 microgram. Less tha 5% of DF leaked out from the liposomes after incubation in mouse plasma for 6 h. 59Fe-ferritin and 59Fe-labelled heat damaged erythrocytes (59Fe-DRBC) were administered to normal and hypertransfused mice as models of iron overload. Ferritin was used to label liver parenchymal cells and DRBC to label the Kupffer cells of the liver. A single injection of ML or UL with or without galactocerebroside into normal and hypertransfused mice enhanced from 3- to 15-fold the urinary excretion of radioiron from 59Fe-ferritin and from 59Fe-DRBC injected mice. For both the normal and hypertransfused mice, liposomes containing GC removed more 59Fe radioactivity from mice receiving 59Fe-DRBC. Thus GAC-liposomes may have a higher affinity for parenchymal cells of the liver, whereas liposomes without the glycolipid may have a higher uptake by the Kupffer cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7213574     DOI: 10.1111/j.1365-2141.1981.tb02679.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  1 in total

1.  Combating iron overload: a case for deferoxamine-based nanochelators.

Authors:  Gregory Jones; Sumanta Kumar Goswami; Homan Kang; Hak Soo Choi; Jonghan Kim
Journal:  Nanomedicine (Lond)       Date:  2020-05-20       Impact factor: 5.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.